Souhaitez-vous accéder aux communiqués récents ?

Rosetta Green and Iowa State University Research Foundation, the licensing arm of Iowa State University, one of the leading universities for plant research, signed a license agreement to develop...

KWS, one of the world's leading plant breeding companies, and Rosetta Green signed a collaboration agreement to develop improved sugar beet plants As part of the agreement, KWS and Rosetta...

Growth hormone is used as a prescription drug to treat children's growth disorders and adult natural growth hormone deficiency. Protein production using microalgae may reduce the high cost of...

Bayer CropScience, a leading crop science company, and Rosetta Green signed a strategic research agreement to identify drought and yield related microRNA in Cotton As part of the agreement,...

The experiment tested a specific microRNA gene that was identified in corn and soybean, and confirmed the potential to develop plants capable of withstanding intermittent irrigation with seawater...

Transition enables the Company to significantly expand plant experiments, while extending experiment duration and increasing the variety of plants in experiments REHOVOT, Israel, Aug. 3, 2011...

REHOVOT, Israel, Aug. 2, 2011 (GLOBE NEWSWIRE) -- Rosetta Green Ltd. ("Company") (TASE:RSTG), which develops improved crop traits for the agriculture and alternative fuels industries using unique...

Rosetta Green will take part in an EU-funded consortium which is led by the Microalgal Biotechnology Laboratory at Ben-Gurion University and will identify microRNA genes to develop algae with...

microRNA genes have a substantial advantage in the ability to improve various traits in plants, such as abiotic stress tolerance. Annual losses due to drought-related damages are estimated at $13...

Production of human a-GAL A protein in microalgae could reduce reliance upon the current high cost methods of production in human and animal cells REHOVOT, Israel, July 10, 2011 (GLOBE...